Showing results (1041-1050 of 1,310) with videos related to

Sort By:
Pageof 131
Antimicrobial Agents and Chemotherapy|December 30, 2016
In Vitro Activity of Posaconazole against Talaromyces marneffei by Broth Microdilution and Etest Methods and Comparison to Itraconazole, Voriconazole, and AnidulafunginSusanna K P Lau, George C S Lo, Clare S K Lam, et al.
Advances in Radiation Oncology|November 24, 2022
Association of Pretreatment Hippocampal Volume With Neurocognitive Function in Patients Treated With Hippocampal Avoidance Whole Brain Radiation Therapy for Brain Metastases: Secondary Analysis of NRG Oncology/RTOG 0933Christopher D Abraham, Stephanie L Pugh, Joseph A Bovi, et al.
Cell Reports|October 14, 2025
Integrated genomic and transcriptomic profiling of glioblastoma reveals ecDNA-driven heterogeneity and microenvironmental reprogrammingWenshu Tang, Wing Lun Lee, Cario W S Lo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 5, 2018
Pericytes Elicit Resistance to Vemurafenib and Sorafenib Therapy in Thyroid Carcinoma via the TSP-1/TGFβ1 AxisAlessandro Prete, Agnes S Lo, Peter M Sadow, et al.
Practical Radiation Oncology|May 24, 2024
External Beam Radiation Therapy for Palliation of Symptomatic Bone Metastases: An ASTRO Clinical Practice GuidelineSara Alcorn, Ángel Artal Cortés, Lisa Bradfield, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 27, 2017
A randomized, phase 2 study of cetuximab plus cisplatin with or without paclitaxel for the first-line treatment of patients with recurrent and/or metastatic squamous cell carcinoma of the head and neckP Bossi, R Miceli, L D Locati, et al.
European Journal of Cancer (Oxford, England : 1990)|November 9, 2016
A phase II study of sorafenib in recurrent and/or metastatic salivary gland carcinomas: Translational analyses and clinical impactL D Locati, F Perrone, B Cortelazzi, et al.
Neuro-Oncology|August 12, 2020
Executive summary from American Radium Society's appropriate use criteria on neurocognition after stereotactic radiosurgery for multiple brain metastasesMichael T Milano, Veronica L S Chiang, Scott G Soltys, et al.
Practical Radiation Oncology|October 24, 2023
Stereotactic Body Radiation Therapy for Gynecologic Malignancies: A Case-Based Radiosurgery Society Practice ReviewColton Ladbury, Mark H Sueyoshi, Nellie M Brovold, et al.
Cancer Cell|January 21, 2015
Tunable-combinatorial mechanisms of acquired resistance limit the efficacy of BRAF/MEK cotargeting but result in melanoma drug addictionGatien Moriceau, Willy Hugo, Aayoung Hong, et al.
Pageof 131